Suscribirse

What lessons can be drawn from a school-based HPV vaccination campaign in Nouvelle-Aquitaine, France, 2023–2024? - 14/02/26

Doi : 10.1016/j.idnow.2025.105241 
Gaëlle Gault a, ⁎ , Alice Herteau a, Philémon Bassan a, Céline Valadeau b, Corine Héron Rougier c, Sylvie Quelet d, Laurent Filleul a
a Public Health France (SPF), Regional Unit Nouvelle-Aquitaine, France 
b Nouvelle-Aquitaine Agency Overseeing Medicines, Medical Devices and Therapeutic Innovation (OMEDIT-NA), France 
c Local Education Authority, Bordeaux, France 
d Regional Health Agency (ARS), Nouvelle-Aquitaine, France 

⁎ Corresponding author.

Abstract

Objectives

In 2023, as a response to low vaccination coverage against human papillomavirus (HPV), a nationwide free HPV vaccination campaign was implemented in French schools, targeting students aged 12–13 years. An evaluation of this campaign was carried out in the Nouvelle-Aquitaine region to identify the factors associated with refusal of school-based vaccination, (barriers as well as levers to adherence), and to estimate its overall impact on vaccination coverage.

Method

Vaccination of students with parental consent was organized in all volunteering public and private middle schools by vaccination centers in Nouvelle-Aquitaine between September 2023 and June 2024. The study was based on data collected on parental decision forms and by vaccination centers, after anonymization. Parents completed two online surveys, one during the collection of parental decision forms and the other after vaccination. Vaccination coverage gains were estimated from HPV vaccines administered in schools and in general practices during the campaign.

Results

Despite the low participation of private schools, the vaccination campaign was well- accepted, as 25 % of students were vaccinated. While the campaign also encouraged vaccination of students by general practitioners (GPs), it did not reduce inequalities in vaccination coverage. The evaluation process highlighted the key role of GPs in decision-making and attained a substantial increase in HPV vaccination coverage among the target population (+28 to + 29 points), partially due to the anticipation of vaccination.

Conclusions

Based on these promising results, school-based vaccination campaigns could substantially contribute to the prevention of HPV-related cancers. This would not only pave the way for other prevention campaigns, but also improvs vaccine access for populations with limited access to healthcare.

El texto completo de este artículo está disponible en PDF.

Keywords : Human papillomavirus vaccine, Vaccination campaign, School, Levers


Esquema


© 2026  Elsevier Masson SAS. Reservados todos los derechos.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 56 - N° 2

Artículo 105241- février 2026 Regresar al número
Artículo precedente Artículo precedente
  • Characteristics of tuberculosis in elderly adults: A multicenter French study
  • Martin Trichet, Jean-Philippe Lanoix, Sylvain Diamantis, Emmanuel Forestier, Thibaut Fraisse, Julia Brochard-Libois, Carine Dokoula, Flora Ketz, Aurélia Henn, Alain Putot, Benoît Cazenave, Nicolas Baclet, Cédric De Villelongue, Nadège Lemarie, Claire Roubaud-Baudron, Gaëtan Gavazzi, Benoît De Wazières, Sébastien Gallien, Pauline Caraux-Paz, On behalf of GInGer
| Artículo siguiente Artículo siguiente
  • Standard- versus high-dose tigecycline in pneumonia due to carbapenem-resistant Acinetobacter baumannii: A propensity score–matched retrospective study
  • Özge Özgen-Top, Pınar Aysert-Yildiz, Zeynep Tekin-Taş, Şeyma Arslan, Emincan Erkan, Fatma Zehra Özcan, Elif Ayça Şahin, Murat Dizbay

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

¿Ya suscrito a @@106933@@ revista ?

@@150455@@ Voir plus

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2026 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.